We are live on ! Find out more
JDOC icon

JPMorgan Healthcare Leaders ETF

3 hedge funds and large institutions have $10.4M invested in JPMorgan Healthcare Leaders ETF in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

96.23% more ownership

Funds ownership: 0%96.23% (+96%)

Holders
3
Holders Change
+3
Holders Change %
% of All Funds
0.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$3.71M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.57M
3
JP Morgan Chase
JP Morgan Chase
New York
+$2.56M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
Jane Street
1
Jane Street
New York
$3.91M +$3.71M +72,592 New
Citadel Advisors
2
Citadel Advisors
Florida
$3.76M +$3.57M +69,872 New
JP Morgan Chase
3
JP Morgan Chase
New York
$2.69M +$2.56M +50,000 New

JDOC Hedge Fund Activity: Q4 2023 in Review

3 of the 6,865 institutional investors tracked by Wall St. Rank reported a position in JPMorgan Healthcare Leaders ETF (JDOC) for Q4 2023, worth a combined $10.4M.

Buyers outnumbered sellers: 3 funds opened new JDOC positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $3.71M.

  • 3 institutional investors held JPMorgan Healthcare Leaders ETF (JDOC) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $10.4M of JPMorgan Healthcare Leaders ETF stock for Q4 2023.
  • 3 funds opened new JPMorgan Healthcare Leaders ETF positions in Q4 2023 and 0 closed out, a net change of +3 holders.
  • The largest JPMorgan Healthcare Leaders ETF buyer in Q4 2023 was Jane Street, an estimated $3.71M added.

Based on aggregated 13F filings for Q4 2023.